Posts Tagged: Belarus

Russian Federation’s updated patent law puts public health first

15 Apr 2021

News

The Russian Federation parliament voted this week (13 April 2021) to enshrine into the law the country’s right to enact...

Read more about Russian Federation’s updated patent law puts public health first

Belarus: Civil society pushes for compulsory license as dolutegravir remains overpriced

4 Aug 2020

Call to action News

Positive Movement (PMPlus) in Belarus, one of our partner organizations, is an NGO representing people living with HIV, advocating for...

Read more about Belarus: Civil society pushes for compulsory license as dolutegravir remains overpriced

Letter to ViiV Healthcare: No more time to waste – increase access to dolutegravir in Eastern Europe and Central Asia

9 Jul 2020

News Press release

Dolutegravir is an essential drug in HIV treatment, recommended by the World Health Organization (WHO). Despite the drug being approved...

Read more about Letter to ViiV Healthcare: No more time to waste – increase access to dolutegravir in Eastern Europe and Central Asia

Activists urge Eurasian states to order more affordable medicines, after HIV patent is dropped

30 Apr 2020

Call to action News

AbbVie has waived its patent rights for HIV drug, lopinavir/ritonavir (LPV/r), in many parts of the world, including for the...

Read more about Activists urge Eurasian states to order more affordable medicines, after HIV patent is dropped